NDC product
Esomeprazole magnesium
NDC 69097-529 · Cipla USA Inc.
Key facts
| Product NDC | 69097-529 |
|---|---|
| Proprietary name | Esomeprazole magnesium |
| Nonproprietary name | Esomeprazole magnesium |
| Substances | ESOMEPRAZOLE MAGNESIUM DIHYDRATE |
| Dosage form | FOR SUSPENSION |
| Route | ORAL |
| Labeler | Cipla USA Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA211751 |
| Pharmacologic classes | Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA] |
| Marketing start | Mar 24, 2020 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: